Quick Answer
Vistagen Therapeutics, Inc. reported Total Assets of $84.34 million for fiscal year 2025.
Vistagen Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $84.34M | -31.8% |
| 2024 | $123.65M | +486.3% |
| 2023 | $21.09M | -71.7% |
| 2022 | $74.64M | -31.1% |
| 2021 | $108.28M | +1775.9% |
| 2020 | $5.77M | -58.8% |
| 2019 | $14.01M | +24.2% |
| 2018 | $11.28M | +203.8% |
| 2017 | $3.71M | +275.0% |
| 2016 | $989.8K | +267.0% |
| 2015 | $269.7K | +2.3% |
| 2014 | $263.7K | -70.1% |
| 2013 | $881.5K | +158.1% |
| 2012 | $341.6K | +5.6% |
| 2011 | $323.6K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $65.06M | -29.5% | -19.6% |
| September 30, 2025 | $80.93M | -21.0% | +17.4% |
| June 30, 2025 | $68.92M | -39.3% | -18.3% |
| March 31, 2025 | $84.34M | -31.8% | -8.6% |
| December 31, 2024 | $92.31M | -29.6% | -9.9% |
| September 30, 2024 | $102.50M | +142.9% | -9.7% |
| June 30, 2024 | $113.55M | +655.4% | -8.2% |
| March 31, 2024 | $123.65M | +486.3% | -5.7% |
- Vistagen Therapeutics, Inc. showed a decrease of -31.8% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Vistagen Therapeutics, Inc.’s total assets has grown by 25963.3% (from $323.6 thousand to $84.34 million).
- The most recent figure is from Vistagen Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: